Seo J, Koh J, Lee DW, Kim J, et al. HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results. Breast Cancer Res 2023;25:154.
PMID: 38098054